GLENMARK LIFE SCIENCES
|
The Current P/S Ratio of GLENMARK LIFE SCIENCES is 6.14.
Share Price | ₹1,149.6 | Sep 06,2024 |
Market Cap | ₹14,082.0 Cr | |
Sales-TTM | ₹2,293.4 Cr | TTM-Standalone Results |
Price/Sales | 6.14x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLENMARK LIFE SCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹14,082.0 Cr] as on Sep 06,2024
(/) Sales [ ₹2,293.4 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 6.14x ]
Thus, for GLENMARK LIFE SCIENCES , the investors are currently willing to pay '6.14 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLENMARK LIFE SCIENCES !
The chart below summarizes the trend in P/S Ratio of GLENMARK LIFE SCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of GLENMARK LIFE SCIENCES
PS Ratio Performance Analysis for GLENMARK LIFE SCIENCES
- GLENMARK LIFE SCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.81x.
- GLENMARK LIFE SCIENCES 's operated at median p/e ratio of 2.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLENMARK LIFE SCIENCES 's p/e ratio peaked in Mar2024 at 4.16x.
- GLENMARK LIFE SCIENCES 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does GLENMARK LIFE SCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLENMARK LIFE SCIENCES | 2,293.4 | 6.14 | 14,082.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 49,208.8 | 8.89 | 437,483.0 |
CIPLA LTD | 26,139.1 | 4.98 | 130,171.0 |
DR REDDYS LABORATORIES LTD | 28,949.3 | 3.84 | 111,298.0 |
ZYDUS LIFESCIENCES LTD | 20,615.3 | 5.37 | 110,736.0 |
DIVIS LABORATORIES LTD | 8,185.0 | 16.67 | 136,472.0 |
MANKIND PHARMA LTD | 10,649.6 | 9.12 | 97,120.1 |
TORRENT PHARMACEUTICALS LTD | 10,996.0 | 10.52 | 115,647.0 |
LUPIN LTD | 20,797.1 | 4.95 | 102,962.0 |
AUROBINDO PHARMA LTD | 29,718.4 | 3.03 | 90,146.6 |
ABBOTT INDIA LTD | 5,927.5 | 10.74 | 63,637.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLENMARK LIFE SCIENCES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 3.03x |
Max industry PS | 16.67x |
Median industry PS | 6.14x |
Average industry PS | 7.66x |
You may also like the below Video Courses